REGN

Regeneron Pharmaceuticals Inc

$807.66

7.98 (1.00%) Today

1.69 (0.21%) After-hours

— up— down

Compare REGN

Market Cap

$82.16B+43.5%

Revenue (TTM)

$15.36B+9.3%

Net Income (TTM)

$4.24B+1.9%

EPS (TTM)

40.45+1.9%

Shares Out

104.84M

P/E Ratio

18.98

Forward P/E

14.12

Dividend

$3.44 (0.47%)

Ex-Dividend Date

May 20, 2026

Open

$802.21

Previous Close

$797.99

Day Range

$794.49 – $815.68

52-Week Range

$541.00 – $821.11

Beta

0.15

Volume

681.26K

Avg Volume

931.33K

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About REGN

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.